Skip to main content

‘Mike King’

Episode 4 | Meet our Faculty | Mike King

Jun. 30, 2023—Learn more about Prof. Michael King and his group. The King Lab utilizes nanostructured surfaces and lipid nanoparticles to study the mechanobiology of circulating cancer and immune cells, and for drug delivery strategies to target metastatic cells in the blood and lymphatic circulation. Watch on YouTube | Hear more from Mike King King Lab

Read more


Dissertation Defense: Maria Lopez Cavestany, Biomedical Engineering

Jun. 27, 2023—DISSERTATION DEFENSE Maria Lopez Cavestany, Biomedical Engineering *under the direction of Mike King “Engineered Models and Therapeutics for Metastatic Colorectal Cancer” 07.05.23  |  2:00PM CST  |  134 Featheringill Hall |   Zoom In the United States, cancer deaths have dropped by 27% in the last 20 years. Although there has been great progress, effective treatment options for metastatic...

Read more


Dissertation Defense: Jenna Dombroski, Biomedical Engineering

May. 9, 2023—DISSERTATION DEFENSE Jenna Dombroski, Biomedical Engineering *under the direction of Mike King “Nano-vaccines and dendritic cell processing for anti-cancer therapies” 05.18.23  |  12:00PM CST  |  5326 Stevenson Center  |   Zoom 1 in 8 women are diagnosed with breast cancer in her lifetime, representing a need for effective preventative measures and therapeutics. Dendritic cells (DCs) can be useful...

Read more


Innovative engineering method could help defang COVID-19 virus of its spike proteins, leading to new prevention options

Apr. 6, 2023—Two Vanderbilt engineering professors, including VINSE faculty member Mike King, could revolutionize the treatment of COVID-19 and related viral infections through research using nanotechnology to remove spike proteins from the viruses. Michael R. King, J. Lawrence Wilson Professor and chair of the Department of Biomedical Engineering, and Zhenjiang Zhang, research assistant professor of Biomedical Engineering, discuss...

Read more


“Piezo1 Mechano-Activation Is Augmented by Resveratrol and Differs between Colorectal Cancer Cells of Primary and Metastatic Origin” published in Molecules, selected as VINSE spotlight publication

Feb. 21, 2023—Josh Greenlee is an NSF Graduate Research Fellow in the Michael King Laboratory where he has spent the last five-and-a-half years working toward his PhD. Josh’s research is focused on understanding mechanisms of metastasis and chemoresistance in colorectal cancer in order to identify weaknesses that can be exploited with targeted therapies.  Josh’s recent publication in...

Read more


Master’s Thesis Presentation: Olivia Wright, Biomedical Engineering

Feb. 13, 2023—MASTERS RESEARCH PRESENTATION Olivia Wright, Biomedical Engineering *under the direction of Dr. Michael King “Superhydrophobic array devices for the production of a tunable in vitro CTC cluster model” 02.15.23 | 3:30pm | 5326 Stevenson Center Cancer metastasis, the spread cancer to a secondary organ, mainly occurs by tumor cells detaching from the primary site and...

Read more


Dissertation Defense, Joshua Greenlee, Biomedical Engineering

Jan. 25, 2023—DISSERTATION DEFENSE Joshua Dale Greenlee, Biomedical Engineering *under the direction of Dr. Michael King “TRAIL Therapy for Exploiting Mechanisms of Drug Resistance and Metastasis in Advanced Colorectal Cancer” 02.23.23  |  9:30am  |  Light Hall 208  |  Zoom Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, accounting for over...

Read more


Michael R. King named National Academy of Inventors Fellow

Dec. 8, 2022—Vanderbilt University engineering professor and VINSE faculty member Michael R. King has been elected a fellow of the National Academy of Inventors. The NAI Fellows Program recognizes academic inventors who have created or facilitated outstanding inventions that make a tangible impact on quality of life, economic development, and the welfare of society. Election to NAI...

Read more


King and Weiss named 2021 AAAS Fellows

Jan. 26, 2022—Two Vanderbilt engineering faculty members–Sharon Weiss and Michael King–have been elected as 2021 Fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. The lifetime appointment honors individuals for their efforts in advancing science applications that are deemed scientifically or socially distinguished. Election as an AAAS Fellow is an...

Read more


Spotlight Publication: “Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress” published in Molecular Cancer Therapeutics

Dec. 1, 2021—“Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress” published in Molecular Cancer Therapeutics has been selected as a VINSE spotlight publication. About the author: Korie Grayson (koriegrayson.com) earner her PhD in Biomedical Engineering in May 2020 from Cornell University under the direction of Prof. Michael King. She was a visiting...

Read more